TCS 3,246.10 -47.45 (-1.44%) 
HDFCBANK 1,765.50 -3.60 (-0.20%) HINDUNILVR 2,349.45 +60.10 (2.63%) INFY 1,404.20 -25.10 (-1.76%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,715.70 -4.30 (-0.25%) KOTAKBANK 2,053.05 -1.40 (-0.07%) ICICIBANK 1,300.50 +1.20 (0.09%) ITC 416.15 +3.60 (0.87%) BAJFINANCE 8,727.05 -93.55 (-1.06%) MARUTI 11,461.95 +5.65 (0.05%) HCLTECH 1,380.45 -22.75 (-1.62%) SBIN 742.05 -26.35 (-3.43%) NESTLEIND 2,344.50 +69.25 (3.04%) ASIANPAINT 2,409.70 +15.55 (0.65%) WIPRO 236.65 -10.60 (-4.29%) DMART 4,140.10 +88.05 (2.17%) AXISBANK 1,061.65 -15.85 (-1.47%) LT 3,059.10 -102.10 (-3.23%) HDFCLIFE 684.80 -1.50 (-0.22%) SUNPHARMA 1,652.10 -36.65 (-2.17%) ULTRACEMCO 11,393.05 +116.30 (1.03%) ONGC 222.20 -4.45 (-1.96%) BAJAJFINSV 1,896.40 -6.55 (-0.34%) BPCL 287.85 +2.15 (0.75%) POWERGRID 293.30 +4.50 (1.56%) TITAN 3,175.20 +51.95 (1.66%) BRITANNIA 5,336.45 +157.40 (3.04%) NTPC 348.75 -4.20 (-1.19%) Download Unicorn Signals App
By EquityPandit
Lupin has launched specialty drug Solosec in US. It is an antimicrobial agent for treating gynecologic infection, among adult women in US.
Last year in September, it had received an approval from USFDA. It’s the first antibiotic pill in the market to treat bacterial vaginosis (BV), which is the most common vaginal infection in the US among women of childbearing age.
Further, the drug is eligible for at least 10 years of marketing exclusivity in US and it is a single dose oral regimen.
